Immunological function of sphingosine 1-phosphate in the intestine

Nutrients

Volumn 4, Issue 3, 2012, Pages 154-166

  Kunisawa, Jun ^a   Kiyono, Hiroshi ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Food allergy; IgA antibody; Intestinal immunity; Intraepithelial T lymphocytes; Lipid

Indexed keywords

FINGOLIMOD; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIN 4; INTERLEUKIN 5; PHOSPHORYLCHOLINE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE;

APICAL MEMBRANE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; DRUG ACTIVITY; ENTERITIS; ENZYME ACTIVITY; ERYTHROCYTE; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LIPID ABSORPTION; LIPID TRANSPORT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MAST CELL; MOLECULAR DYNAMICS; NONHUMAN; PERITONEAL CAVITY; PEYER PATCH; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; T LYMPHOCYTE; THROMBOCYTE; THYMOCYTE; TISSUE DISTRIBUTION;

EID: 84858960553     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu4030154     Document Type: Review

References (53)

1. Kiyono, H.; Kunisawa, J.; McGhee, J.R.; Mestecky, J. The Mucosal Immune System. In Fundamental Immunology; Paul, W.E., Ed.; Lippincott-Raven: Philadelphia, PA, USA, 2008; Volume 6, pp. 983-1030.
2. Maslowski, K.M.; Mackay, C.R. Diet, gut microbiota and immune responses. Nat. Immunol. 2011, 12, 5-9.
3. Margioris, A.N. Fatty acids and postprandial inflammation. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12, 129-137.
4. Chi, H. Sphingosine-1-phosphate and immune regulation: Trafficking and beyond. Trends Pharmacol. Sci. 2011, 32, 16-24.
5. Rivera, J.; Proia, R.L.; Olivera, A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 2008, 8, 753-763.
6. Pappu, R.; Schwab, S.R.; Cornelissen, I.; Pereira, J.P.; Regard, J.B.; Xu, Y.; Camerer, E.; Zheng, Y.W.; Huang, Y.; Cyster, J.G.; et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007, 316, 295-298.
7. Schwab, S.R.; Pereira, J.P.; Matloubian, M.; Xu, Y.; Huang, Y.; Cyster, J.G. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 2005, 309, 1735-1739.
8. Matloubian, M.; Lo, C.G.; Cinamon, G.; Lesneski, M.J.; Xu, Y.; Brinkmann, V.; Allende, M.L.; Proia, R.L.; Cyster, J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427, 355-360.
9. Michaud, J.; Im, D.S.; Hla, T. Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation. J. Immunol. 2010, 184, 1475-1483.
10. Maeda, Y.; Matsuyuki, H.; Shimano, K.; Kataoka, H.; Sugahara, K.; Chiba, K. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. J. Immunol. 2007, 178, 3437-3446.
11. Walzer, T.; Chiossone, L.; Chaix, J.; Calver, A.; Carozzo, C.; Garrigue-Antar, L.; Jacques, Y.; Baratin, M.; Tomasello, E.; Vivier, E. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol. 2007, 8, 1337-1344.
12. Liu, G.; Yang, K.; Burns, S.; Shrestha, S.; Chi, H. The S1P1-mTOR axis directs the reciprocal differentiation of Th1 and Treg cells. Nat. Immunol. 2010, 11, 1047-1056.
13. Wang, W.; Huang, M.C.; Goetzl, E.J. Type 1 sphingosine 1-phosphate G protein-coupled receptor (S1P1) mediation of enhanced IL-4 generation by CD4 T cells from S1P1 transgenic mice. J. Immunol. 2007, 178, 4885-4890.
14. Huang, M.C.; Watson, S.R.; Liao, J.J.; Goetzl, E.J. Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J. Immunol. 2007, 178, 6806-6813.
15. Oskeritzian, C.A.; Price, M.M.; Hait, N.C.; Kapitonov, D.; Falanga, Y.T.; Morales, J.K.; Ryan, J.J.; Milstien, S.; Spiegel, S. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J. Exp. Med. 2010, 207, 465-474.
16. Hughes, J.E.; Srinivasan, S.; Lynch, K.R.; Proia, R.L.; Ferdek, P.; Hedrick, C.C. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ. Res. 2008, 102, 950-958.
17. Bouhours, D.; Bouhours, J.F. Developmental changes of monohexosylceramide and free ceramide in the large intestine of the rat. J. Biochem. 1985, 98, 1359-1366.
18. Gustafsson, B.E.; Karlsson, K.A.; Larson, G.; Midtvedt, T.; Stromberg, N.; Teneberg, S.; Thurin, J. Glycosphingolipid patterns of the gastrointestinal tract and feces of germ-free and conventional rats. J. Biol. Chem. 1986, 261, 15294-15300.
19. Vesper, H.; Schmelz, E.M.; Nikolova-Karakashian, M.N.; Dillehay, D.L.; Lynch, D.V.; Merrill, A.H., Jr. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr. 1999, 129, 1239-1250.
20. Nilsson, A. Metabolism of sphingomyelin in the intestinal tract of the rat. Biochim. Biophys. Acta 1968, 164, 575-584.
21. Schmelz, E.M.; Crall, K.J.; Larocque, R.; Dillehay, D.L.; Merrill, Jr A.H., Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J. Nutr. 1994, 124, 702-712.
22. Nilsson, A.; Duan, R.D. Alkaline sphingomyelinases and ceramidases of the gastrointestinal tract. Chem. Phys. Lipids 1999, 102, 97-105.
23. Tani, M.; Ito, M.; Igarashi, Y. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell. Signal. 2007, 19, 229-237.
24. Duan, R.D.; Nilsson, A. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog. Lipid Res. 2009, 48, 62-72.
25. Mazzei, J.C.; Zhou, H.; Brayfield, B.P.; Hontecillas, R.; Bassaganya-Riera, J.; Schmelz, E.M. Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: Importance of peroxisome proliferator-activated receptor gamma expression. J. Nutr. Biochem. 2011, 22, 1160-1171.
26. Fischbeck, A.; Leucht, K.; Frey-Wagner, I.; Bentz, S.; Pesch, T.; Kellermeier, S.; Krebs, M.; Fried, M.; Rogler, G.; Hausmann, M.; et al. Sphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitis. Gut 2011, 60, 55-65.
27. Sjoqvist, U.; Hertervig, E.; Nilsson, A.; Duan, R.D.; Ost, A.; Tribukait, B.; Lofberg, R. Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm. Bowel Dis. 2002, 8, 258-263.
28. Maines, L.W.; Fitzpatrick, L.R.; French, K.J.; Zhuang, Y.; Xia, Z.; Keller, S.N.; Upson, J.J.; Smith, C.D. Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig. Dis. Sci. 2008, 53, 997-1012.
29. Nyberg, L.; Duan, R.D.; Nilsson, A. A mutual inhibitory effect on absorption of sphingomyelin and cholesterol. J. Nutr. Biochem. 2000, 11, 244-249.
30. Allende, M.L.; Bektas, M.; Lee, B.G.; Bonifacino, E.; Kang, J.; Tuymetova, G.; Chen, W.; Saba, J.D.; Proia, R.L. Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. J. Biol. Chem. 2011, 286, 7348-7358.
31. Bagdanoff, J.T.; Donoviel, M.S.; Nouraldeen, A.; Tarver, J.; Fu, Q.; Carlsen, M.; Jessop, T.C.; Zhang, H.; Hazelwood, J.; Nguyen, H.; et al. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. J. Med. Chem. 2009, 52, 3941-3953.
32. Bandhuvula, P.; Honbo, N.; Wang, G.Y.; Jin, Z.Q.; Fyrst, H.; Zhang, M.; Borowsky, A.D.; Dillard, L.; Karliner, J.S.; Saba, J.D. S1p lyase: A novel therapeutic target for ischemia-reperfusion injury of the heart. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H1753-H1761.
33. Kunisawa, J.; McGhee, J.; Kiyono, H. Mucosal S-IgA Enhancement: Development of Safe and Effective Mucosal Adjuvants and Mucosal Antigen Delivery Vehicles. In Mucosal Immune Defense: Immunoglobulin A; Kaetzel, C., Ed.; Kluwer Academic/Plenum Publishers: New York, NY, USA, 2007; pp. 346-389.
34. Fagarasan, S.; Kawamoto, S.; Kanagawa, O.; Suzuki, K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu. Rev. Immunol. 2010, 28, 243-273.
35. Kunisawa, J.; Nochi, T.; Kiyono, H. Immunological commonalities and distinctions between airway and digestive immunity. Trends Immunol. 2008, 29, 505-513.
36. Neutra, M.R.; Mantis, N.J.; Kraehenbuhl, J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2001, 2, 1004-1009.
37. Gohda, M.; Kunisawa, J.; Miura, F.; Kagiyama, Y.; Kurashima, Y.; Higuchi, M.; Ishikawa, I.; Ogahara, I.; Kiyono, H. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses. J. Immunol. 2008, 180, 5335-5343.
38. Graler, M.H.; Goetzl, E.J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 2004, 18, 551-553.
39. Kunisawa, J.; Kiyono, H. A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense. Cell Mol. Life Sci. 2005, 62, 1308-1321.
40. Kunisawa, J.; Kurashima, Y.; Gohda, M.; Higuchi, M.; Ishikawa, I.; Miura, F.; Ogahara, I.; Kiyono, H. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production. Blood 2007, 109, 3749-3756.
41. Kunisawa, J.; Gohda, M.; Kurashima, Y.; Ishikawa, I.; Higuchi, M.; Kiyono, H. Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFκB-inducing kinase in stromal cells. Blood 2008, 111, 4646-4652.
42. Kunisawa, J.; Takahashi, I.; Kiyono, H. Intraepithelial lymphocytes: Their shared and divergent immunological behaviors in the small and large intestine. Immunol. Rev. 2007, 215, 136-153.
43. Vivier, E.; Tomasello, E.; Paul, P. Lymphocyte activation via NKG2D: Towards a new paradigm in immune recognition? Curr. Opin. Immunol. 2002, 14, 306-311.
44. Natarajan, K.; Dimasi, N.; Wang, J.; Mariuzza, R.A.; Margulies, D.H. Structure and function of natural killer cell receptors: Multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 2002, 20, 853-885.
45. Gangadharan, D.; Lambolez, F.; Attinger, A.; Wang-Zhu, Y.; Sullivan, B.A.; Cheroutre, H. Identification of pre- and postselection TCRαβ+ intraepithelial lymphocyte precursors in the thymus. Immunity 2006, 25, 631-641.
46. Kunisawa, J.; Kurashima, Y.; Higuchi, M.; Gohda, M.; Ishikawa, I.; Ogahara, I.; Kim, N.; Shimizu, M.; Kiyono, H. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J. Exp. Med. 2007, 204, 2335-2348.
47. Sharma, S.; Mathur, A.G.; Pradhan, S.; Singh, D.B.; Gupta, S. Fingolimod (FTY720): First approved oral therapy for multiple sclerosis. J. Pharmacol. Pharmacother. 2011, 2, 49-51.
48. Kweon, M.N.; Yamamoto, M.; Kajiki, M.; Takahashi, I.; Kiyono, H. Systemically derived large intestinal CD4+ Th2 cells play a central role in STAT6-mediated allergic diarrhea. J. Clin. Invest. 2000, 106, 199-206.
49. Kurashima, Y.; Kunisawa, J.; Higuchi, M.; Gohda, M.; Ishikawa, I.; Takayama, N.; Shimizu, M.; Kiyono, H. Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy. J. Immunol. 2007, 179, 1577-1585.
50. Gurish, M.F.; Boyce, J.A. Mast cell growth, differentiation, and death. Clin. Rev. Allergy Immunol. 2002, 22, 107-118.
51. Mizushima, T.; Ito, T.; Kishi, D.; Kai, Y.; Tamagawa, H.; Nezu, R.; Kiyono, H.; Matsuda, H. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis. Inflamm. Bowel Dis. 2004, 10, 182-192.
52. - effector memory T cell-mediated colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291, G267-G274.
53. Deguchi, Y.; Andoh, A.; Yagi, Y.; Bamba, S.; Inatomi, O.; Tsujikawa, T.; Fujiyama, Y. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Oncol. Rep. 2006, 16, 699-703.